Get started
Nuvation Bio Inc.Nuvation Bio Inc.Nuvation Bio Inc.

Nuvation Bio Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

NUVB chart


Full chart

Key facts today

RBC Capital raised the price target for Nuvation Bio Inc. (NUVB) to $6.00 per share from $5.00.
Analyze the impactAnalyze the impact

NUVB upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪884.42 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.17 USD
Net income (FY)
‪−75.80 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪227.21 M‬
Beta (1Y)
2.17

Employees


Employees (FY)
51
Change (1Y)
−2 −3.77%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.49 M‬ USD

About Nuvation Bio Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
David T. Hung
Website
nuvationbio.com
Headquarters
New York
Founded
2018
FIGI
BBG00VHJ0CC1
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

NUVB news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NUVB is 2.76 USD — it has increased by 3.15% in the past 24 hours. Watch Nuvation Bio Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Nuvation Bio Inc. stocks are traded under the ticker NUVB.
NUVB stock has risen by 13.42% compared to the previous week, the month change is a 13.42% rise, over the last year Nuvation Bio Inc. has showed a 99.64% increase.
We've gathered analysts' opinions on Nuvation Bio Inc. future price: according to them, NUVB price has a max estimate of 8.00 USD and a min estimate of 5.00 USD. Watch NUVB chart and read a more detailed Nuvation Bio Inc. stock forecast: see what analysts think of Nuvation Bio Inc. and suggest that you do with its stocks.
NUVB reached its all-time high on May 26, 2021 with the price of 15.23 USD, and its all-time low was 0.95 USD and was reached on Oct 31, 2023. View more price dynamics on NUVB chart.
See other stocks reaching their highest and lowest prices.
NUVB stock is 12.36% volatile and has beta coefficient of 2.17. Track Nuvation Bio Inc. stock price on the chart and check out the list of the most volatile stocks — is Nuvation Bio Inc. there?
Today Nuvation Bio Inc. has the market capitalization of ‪877.12 M‬, it has increased by 1.74% over the last week.
Yes, you can track Nuvation Bio Inc. financials in yearly and quarterly reports right on TradingView.
Nuvation Bio Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
NUVB earnings for the last quarter are −0.15 USD per share, whereas the estimation was −0.13 USD resulting in a −19.05% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about Nuvation Bio Inc. earnings.
Nuvation Bio Inc. revenue for the last quarter amounts to ‪727.00 K‬ USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
NUVB net income for the last quarter is ‪−41.21 M‬ USD, while the quarter before that showed ‪−462.49 M‬ USD of net income which accounts for 91.09% change. Track more Nuvation Bio Inc. financial stats to get the full picture.
No, NUVB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 51.00 employees. See our rating of the largest employees — is Nuvation Bio Inc. on this list?
Like other stocks, NUVB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nuvation Bio Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nuvation Bio Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nuvation Bio Inc. stock shows the neutral signal. See more of Nuvation Bio Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.